Nature Communications (Sep 2024)

Crinophagic granules in pancreatic β cells contribute to mouse autoimmune diabetes by diversifying pathogenic epitope repertoire

  • Hao Hu,
  • Anthony N. Vomund,
  • Orion J. Peterson,
  • Neetu Srivastava,
  • Tiandao Li,
  • Lisa Kain,
  • Wandy L. Beatty,
  • Bo Zhang,
  • Chyi-Song Hsieh,
  • Luc Teyton,
  • Cheryl F. Lichti,
  • Emil R. Unanue,
  • Xiaoxiao Wan

DOI
https://doi.org/10.1038/s41467-024-52619-5
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 22

Abstract

Read online

Abstract Autoimmune attack toward pancreatic β cells causes permanent loss of glucose homeostasis in type 1 diabetes (T1D). Insulin secretory granules store and secrete insulin but are also thought to be tissue messengers for T1D. Here, we show that the crinophagic granules (crinosome), a minor set of vesicles formed by fusing lysosomes with the conventional insulin dense-core granules (DCG), are pathogenic in T1D development in mouse models. Pharmacological inhibition of crinosome formation in β cells delays T1D progression without affecting the dominant DCGs. Mechanistically, crinophagy inhibition diminishes the epitope repertoire in pancreatic islets, including cryptic, modified and disease-relevant epitopes derived from insulin. These unconventional insulin epitopes are largely undetectable in the MHC-II epitope repertoire of the thymus, where only canonical insulin epitopes are presented. CD4+ T cells targeting unconventional insulin epitopes display autoreactive phenotypes, unlike tolerized T cells recognizing epitopes presented in the thymus. Thus, the crinophagic pathway emerges as a tissue-intrinsic mechanism that transforms insulin from a signature thymic self-protein to a critical autoantigen by creating a peripheral-thymic mismatch in the epitope repertoire.